InvestorsHub Logo
Followers 28
Posts 2610
Boards Moderated 0
Alias Born 01/06/2009

Re: Stock_Barber post# 45834

Friday, 08/16/2013 3:16:50 PM

Friday, August 16, 2013 3:16:50 PM

Post# of 130746
They clearly are speaking of the market the MPDD resides in as having an estimated $4.5 billion in device sales, etc. etc.
You have misinterpreted the statement whether by accident or not.

EPGL Med ?@EPGLMed 3 Jan
John, The projections we have released is 15,000 units per year as the goal for worldwide distribution and sales for MPDD.



15,000 x $15,000(avg.) = $225,000,000 + recurrent, etc.

The combined national and international market for the MPDD device is estimated at $4.5 billion dollars annually in device sales and recurrent education and training revenues.



If anything, it's poor grammar. Should have read,

The combined national and international market, for the MPDD device, is estimated at $4.5 billion dollars annually in device sales and recurrent education and training revenues.

which could be reworded to,

"For the MPDD device, the combined national and international market is estimated at $4.5 billion dollars annually in device sales and recurrent education and training revenues."


The overall market for chronic pain is $85B.

W

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.